Ticker League

FCF Margin for Pfizer (PFE)

As of · Reported

Metric

TTM

15.0%

YoY change

−0.95pp

Trough year (1992)

1.8%

Peak year (2021)

36.7%

FCF Margin history chart for Pfizer (PFE) from 1989 to 2025

Latest: 14.5%

FCF Margin change chart for Pfizer (PFE) from 1989 to 2025

Latest: −0.95pp

FCF Margin history table for Pfizer (PFE) from 1989 to 2025

  • 202514.5%-0.95pp
  • 202415.5%+7.41pp
  • 20238.0%-17.90pp
  • 202225.9%-10.80pp
  • 202136.7%+8.87pp
  • 202027.9%+3.61pp
  • 201924.3%-1.13pp
  • 201825.4%-1.72pp
  • 201727.1%+0.81pp
  • 201626.3%-0.33pp
  • 201526.6%-4.20pp
  • 201430.8%-0.76pp
  • 201331.6%+2.82pp
  • 201228.8%-1.67pp
  • 201130.4%+15.62pp
  • 201014.8%-15.93pp
  • 200930.8%-3.48pp
  • 200834.2%+10.55pp
  • 200723.7%-8.44pp
  • 200632.1%+5.50pp
  • 200526.6%+0.47pp
  • 200426.2%+6.03pp
  • 200320.1%-5.89pp
  • 200226.0%+4.14pp
  • 200121.9%+8.35pp
  • 200013.5%+4.31pp
  • 19999.2%-3.55pp
  • 199812.8%+7.29pp
  • 19975.5%-5.95pp
  • 199611.4%+0.21pp
  • 199511.2%+1.36pp
  • 19949.9%+1.46pp
  • 19938.4%+6.57pp
  • 19921.8%-1.82pp
  • 19913.7%-1.23pp
  • 19904.9%+1.37pp
  • 19893.5%—

FCF Margin values are taken from Pfizer's reported income statements (quarterly 10-Q and annual 10-K filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the filing date. YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.

About FCF Margin at Pfizer (PFE)

According to Pfizer's latest reported financial statements, the company's latest reported free cash flow margin is 15.0%. Free cash flow margin is free cash flow divided by revenue — the share of each sales dollar that converts into cash after capital expenditures. Because free cash flow cannot be inflated by non-cash accounting, FCF margin is a clean read on how efficiently a business turns revenue into deployable cash.

Headline figure above is from the reporting period ending (reported ). Chart and table below cover the full reported history back to .

Pfizer (PFE) most recent annual free cash flow margin stands at 14.50% (2025) – contracted 1.0 percentage points year-over-year.

2021 marks the peak free cash flow margin at 36.74%, with the historical low of 1.84% recorded in 1992.

Pfizer FCF Margin by Year

Pfizer FCF Margin 2025: 14.5%

2025's free cash flow margin for Pfizer came in at 14.50%, contracted 1.0 percentage points from 2024.

Pfizer FCF Margin 2024: 15.5%

Pfizer posted free cash flow margin of 15.46% in 2024, expanded 7.4 percentage points from 2023.

Pfizer FCF Margin 2023: 8.0%

In 2023, Pfizer reported free cash flow margin of 8.05%, contracted 17.9 percentage points from 2022.

Pfizer FCF Margin 2022: 25.9%

Pfizer free cash flow margin in 2022 was 25.95%, contracted 10.8 percentage points from 2021.

Pfizer FCF Margin 2021: 36.7%

Pfizer free cash flow margin in 2021 was 36.74%.

See more financial history for Pfizer (PFE).

Sector peers by FCF Margin

Healthcare peers of Pfizer (PFE), ranked by their latest free cash flow margin

Frequently asked questions

Pfizer (PFE) Key Financials

Charts, filings, and peer comparison for every metric

Explore more

Deep-dives across the income statement, cash flow, capital return, and valuation

Overview